Alivus Life Sciences Limited (NSE:ALIVUS)

Alivus Life Sciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	21.32	710.62	3,014	2,838	5,122
Short-Term Investments	-	7,804	4,776	-	-	1.11
Cash & Short-Term Investments	7,825	7,825	5,487	3,014	2,838	5,123
Cash Growth	42.57%	42.62%	82.03%	6.20%	-44.59%	332.66%
Accounts Receivable	-	10,730	9,697	7,654	8,068	6,735
Other Receivables	-	322.92	398.65	903.68	709.4	57.94
Receivables	-	11,053	10,096	8,558	8,777	6,793
Inventory	-	6,919	6,739	6,666	6,042	5,162
Prepaid Expenses	-	-	22.56	8.06	1.38	1.63
Other Current Assets	-	696.61	1,007	913.88	845.01	566.28
Total Current Assets	-	26,494	23,352	19,160	18,503	17,646
Property, Plant & Equipment	-	12,914	10,369	8,962	8,242	6,763
Long-Term Investments	-	0.77	0.77	0.77	0.77	0.77
Other Intangible Assets	-	299.26	199.37	148.53	180.01	103.8
Other Long-Term Assets	-	121.57	193.59	232.86	94.86	196.3
Total Assets	-	39,829	34,115	28,504	27,021	24,710

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	3,724	3,905	3,687	4,272	3,077
Accrued Expenses	-	299.11	479.38	385.91	361.1	447.76
Current Portion of Leases	-	79.77	56.48	23.87	22.65	16.8
Current Income Taxes Payable	-	64.58	-	-	70.78	120.03
Current Unearned Revenue	-	-	29.67	52.58	19.43	-
Other Current Liabilities	-	913.22	231.42	238.76	219.21	178.19
Total Current Liabilities	-	5,080	4,702	4,388	4,965	3,840
Long-Term Leases	-	487.94	509.58	147.61	170.92	12.04
Pension & Post-Retirement Benefits	-	361.48	185.35	157.71	78.7	-
Long-Term Deferred Tax Liabilities	-	577.88	544.29	487.85	424.34	314.95
Total Liabilities	-	6,508	5,941	5,181	5,639	4,167

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	245.47	245.07	245.05	245.05	245.05
Additional Paid-In Capital	-	-	10,057	10,050	10,050	10,050
Retained Earnings	-	-	17,772	12,918	11,021	10,214
Comprehensive Income & Other	-	33,076	99.69	110.58	66.83	34.98
Shareholders' Equity	33,321	33,321	28,174	23,323	21,382	20,543
Total Liabilities & Equity	-	39,829	34,115	28,504	27,021	24,710

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	567.71	567.71	566.06	171.48	193.57	28.84
Net Cash (Debt)	7,257	7,257	4,921	2,843	2,645	5,094
Net Cash Growth	47.44%	47.49%	73.10%	7.49%	-48.08%	-
Net Cash Per Share	59.01	59.01	40.04	23.17	21.58	43.34
Filing Date Shares Outstanding	122.76	122.95	122.54	122.53	122.53	122.53
Total Common Shares Outstanding	122.76	122.95	122.54	122.53	122.53	122.53
Working Capital	-	21,413	18,650	14,772	13,538	13,806
Book Value Per Share	271.02	271.02	229.92	190.35	174.51	167.66
Tangible Book Value	33,022	33,022	27,974	23,175	21,202	20,439
Tangible Book Value Per Share	268.58	268.58	228.29	189.14	173.04	166.81
Buildings	-	-	3,678	3,164	3,017	2,235
Machinery	-	-	7,225	6,273	5,743	4,426
Construction In Progress	-	-	942.52	1,012	493.54	916.88

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error